Amy Feldman, Forbes Staff

Author's posts

Serial Biotech Entrepreneur Kevin Ness Has Raised $260 Million To Get His Genome-Engineering Device Into The Hands Of Every Scientist Who Wants One

Serial entrepreneur Kevin Ness has raised $260 million for Inscripta to get his genome-editing device into the hands of every scientist who wants one.

Next Billion-Dollar Startups: Truepill’s Dose Of Digital Disruption To The $400 Billion Pharmacy Industry

America has been buying medicine the same way for centuries, creating a $400 billion industry. Fast-growing Truepill wants to deliver a dose of digital disruption.

Microbe-Hacker Ginkgo Bioworks Pushes Further Into Medicine With Acquisition Of Genome Mining Platform And Antibiotics Discovery Deal With Roche

Gene-hacking unicorn Ginkgo Bioworks pushed further into medicine with the acquisition of Warp Drive Bio’s genome mining platform and its antibiotics discovery deal with Roche. “This is a big part of the future of Ginkgo,” CEO Jason Kelly told Forbes.

New UBiome CEO Is Longtime Restructuring Expert Who Previously Worked With Failed Drone Startup Lily Robotics

UBiome’s new interim CEO is a longtime restructuring expert who previously worked with failed drone startup Lily Robotics.